Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (311-320 of 6,083) with videos related to

Pageof 609
Sort By:
The Prostate|July 13, 2011
Biological significance of perineural invasion (PNI) in prostate cancerGaëlle Fromont, Julie Godet, Christophe Pires, et al.
The Prostate|June 18, 2011
Aberrant expression of katanin p60 in prostate cancer bone metastasisXiangcang Ye, Yu-Chen Lee, Michel Choueiri, et al.
The Prostate|April 2, 2011
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivoParisa Abedinpour, Véronique T Baron, John Welsh, et al.
The Prostate|April 2, 2011
Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 geneNandita Barnabas, Lihua Xu, Adnan Savera, et al.
The Prostate|April 2, 2011
Effect of electroporation-mediated diphtheria toxin A expression on PSA positive human prostate xenograft tumors in SCID miceChristine Goepfert, Amiq Gazdhar, Felix J Frey, et al.
The Prostate|April 2, 2011
Effect of luteinizing hormone on the steroidogenic pathway in prostate cancerJacek Pinski, Shigang Xiong, Qingcai Wang, et al.
The Prostate|June 10, 2011
Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancerHisashi Shimojo, Motohiro Kobayashi, Takayuki Kamigaito, et al.
The Prostate|June 10, 2011
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancerAli Ghadersohi, Satish Sharma, Shaozeng Zhang, et al.
The Prostate|June 10, 2011
Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapyShu-Pin Huang, Bo-Ying Bao, Ming-Tsang Wu, et al.
The Prostate|June 10, 2011
Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cellsMitchell G Lawrence, Naira V Margaryan, Daniela Loessner, et al.
Pageof 609

Showing results (311-320 of 6,083) with videos related to

Sort By:
Pageof 609
The Prostate|July 13, 2011
Biological significance of perineural invasion (PNI) in prostate cancerGaëlle Fromont, Julie Godet, Christophe Pires, et al.
The Prostate|June 18, 2011
Aberrant expression of katanin p60 in prostate cancer bone metastasisXiangcang Ye, Yu-Chen Lee, Michel Choueiri, et al.
The Prostate|April 2, 2011
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivoParisa Abedinpour, Véronique T Baron, John Welsh, et al.
The Prostate|April 2, 2011
Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 geneNandita Barnabas, Lihua Xu, Adnan Savera, et al.
The Prostate|April 2, 2011
Effect of electroporation-mediated diphtheria toxin A expression on PSA positive human prostate xenograft tumors in SCID miceChristine Goepfert, Amiq Gazdhar, Felix J Frey, et al.
The Prostate|April 2, 2011
Effect of luteinizing hormone on the steroidogenic pathway in prostate cancerJacek Pinski, Shigang Xiong, Qingcai Wang, et al.
The Prostate|June 10, 2011
Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancerHisashi Shimojo, Motohiro Kobayashi, Takayuki Kamigaito, et al.
The Prostate|June 10, 2011
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancerAli Ghadersohi, Satish Sharma, Shaozeng Zhang, et al.
The Prostate|June 10, 2011
Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapyShu-Pin Huang, Bo-Ying Bao, Ming-Tsang Wu, et al.
The Prostate|June 10, 2011
Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cellsMitchell G Lawrence, Naira V Margaryan, Daniela Loessner, et al.
Pageof 609